The conference, which will showcase nearly 150 publicly traded and privately held healthcare companies for institutional investors, is scheduled for Wednesday, February 13, 2013 – Thursday, February 14, 2013 at The Waldorf=Astoria in New York City. Quality Systems’ President and Chief Executive Officer Steven T. Plochocki is scheduled to present on Wednesday, February 13, 2013, at 8:00 AM local time. The 25-minute presentation will address the company’s operations and strategy.
A webcast of Quality Systems’ audio presentation will be available on February 13, 2013 (beginning at the start time of the presentation) and can be viewed by accessing http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=123. It will be archived for 90 days.
Founded in 1995, Leerink Swann, member FINRA/SIPC, is a leading healthcare investment bank to a broad range of institutional, life sciences, corporate and high-net-worth clients. For more information, visit www.leerink.com.
Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit www.qsii.com and www.nextgen.com for additional information.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2012, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Quality Systems, Inc.
Susan J. Lewis, 303-804-0494
|Quality Systems, Inc. to Present at the Citi 2013 Global Healthcare Conference (2013/2/19)|
|Fluidigm to Present at Leerink Swann 2013 Global Healthcare Conference (2013/2/7)|
|Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference (2013/2/6)|
|Waters Corporation Presentation at the Leerink Swann 2013 Global Healthcare Conference to Be Webcast Live (2013/2/6)|
|Spectrum Pharmaceuticals to Present Corporate Update at the Leerink Swann 2013 Global Healthcare Conference in New York on February 14th (2013/2/7)|
|Sunesis to Present at the Leerink Swann 2013 Global Healthcare Conference (2013/2/6)|
|Coronado Biosciences to Present at the Leerink Swann 2013 Global Healthcare Conference (2013/2/7)|
|NuPathe to Present at the Leerink Swann 2013 Global Healthcare Conference (2013/2/6)|
|Merck to Present at the Leerink Swann 2013 Global Healthcare Conference (2013/2/12)|
|Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2013 Global Healthcare Conference (2013/5/28)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.